Syneron Candela files patent suits v 18 distributors

Syneron Medical Ltd and its subsidiary Candela Corporation (Syneron Candela) and Massachusetts General Hospital (MGH) said they filed patent infringement complaints against 18 manufacturers and distributors of fractional RF micro-needle dermatological treatment systems in both the US International Trade Commission in Washington, D.C. and in federal district court.

“Fractional RF micro-needle technology was invented by Dr. Dieter Manstein at MGH, who initially filed for patent protection in 2004, and ultimately obtained a series of patents on the groundbreaking technology,” said Syneron Candela.

“Syneron Candela licensed the patents, developed the commercialized product — Profound — that implements the technology, and obtained FDA approval for sales of their RF micro-needle product in the United States.

“Subsequently, the accused companies all entered the market in the U.S. in violation of the patents, as alleged in the complaints.”

Syneron Candela CEO Geoffrey Crouse said: “Today’s suit filed at the ITC seeks to block importation into the U.S. of all fractional RF micro-needle products of Cutera, ilooda, Invasix, Lumenis, Endymed, Jeisys, Lutronic, and Sung Hwan.

“The federal litigation filed today seeks to stop ongoing use of these devices in the U.S. and to collect damages for past infringement.

“Over the years, the company has invested heavily in developing Profound which we believe is the leading fractional RF microneedle system in the world, and we will not permit others to infringe our patent rights.”

Syneron Candela said the suits filed allege infringement of two US Patents: 9,510,899 and 9,095,357, both entitled, “Method and Apparatus for Dermatological Treatment and Tissue Reshaping.”

Syneron Candela added: “The accused infringing products include Secret RF by ilooda Co., Ltd. and Cutera, Inc.; Fraxis Duo by ilooda Co., Ltd., Emvera Technologies, LLC and Rohrer Aesthetics, LLC; Fractora by Invasix Ltd., Invasix, Inc. and InMode MD Ltd.; Legend Pro by Lumenis Ltd and Pollogen Ltd; 3DEEP by EndyMed Medical Ltd. and EndyMed Medical Inc.; INTRAcel by Jeisys Medical, Inc. and Perigee Medical LLC; Infini by Lutronic, Corp. and Lutronic, Inc.; and Vivace by Sung Hwan E&B Co. Ltd, Aesthetics Biomedical, Inc. and Cartessa Aesthetics LLC.”